Podcasts about Peripheral artery disease

Send us a textThis recording features audio versions of June 2025 Journal of Vascular and Interventional Radiology (JVIR) abstracts:Comparison of Bypass Surgery versus Endovascular Interventions for Peripheral Artery Disease through Systematic Review and Meta-Analysis of Randomized Controlled Trials ReadThe Incidence and Consequences of Endovascular Technical Failure in Patients with Chronic Limb-Threatening Ischemia: Results from the Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb-Threatening Ischemia (BEST-CLI) Trial ReadComparative Radiologic Response Assessment after Transarterial Chemoembolization, Percutaneous Ablation, and Multimodal Treatment: Radiologic-Pathologic Correlation in 81 Tumors ReadBreast Cancer Recurrence after Cryoablation in Patients Who Are Poor Surgical Candidates or Who Refuse Surgery ReadKetamine/Midazolam versus Fentanyl/Midazolam Sedation for Interventional Radiology Procedures: A Prospective Registry ReadPortal and Hepatic Vein Embolization versus Portal Venous Embolization Alone in Cirrhotic and Noncirrhotic Swine: A Pilot Study ReadAssessment of Catheter-Directed Thrombolysis and Histotripsy Treatment for Deep Vein Thrombosis ReadExpanding Global IR Outreach to Address Postpartum Hemorrhage in Kenya Using Geospatial Analytic Mapping ReadJVIR and SIR thank all those who helped record this episode. To sign up to help with future episodes, please contact our outreach coordinator at millennie.chen.jvir@gmail.com.  Host and audio Editor:Sonya Choe, University of California Riverside School of MedicineOutreach coordinator:Millennie Chen, University of California Riverside School of MedicineAbstract readers:Marc Attalla, University of California Riverside School of MedicineAgnes Manish, Loma Linda University School of MedicineClare Necas, Western University of Health Sciences, College of Osteopathic MedicineGavin Shu, University of California San Francisco School of MedicineMark Oliinik, Loma Linda University School of MedicineAbhisri Ramesh, George Washington School of Medicine and Health SciencesAndrew Sasser, University of Miami Miller School of Medicine Sakeena Siddiq, Western University of Health Sciences, College of Osteopathic MedicineSIR thanks BD for its generous support of the Kinked Wire.Read more about about interventional radiology in IR Quarterly magazine or SIR's Patient Center.Support the show

Cobert presents with a history of peripheral artery disease and was referred to physical therapy for walking endurance. He reports intermittent claudication in his calves after walking 100 meters and frequently stops to rest. His resting ABI is 0.7 in both legs. The goal is to enhance his functional capacity and quality of life. Which walking program is MOST appropriate to improve this patient's functional capacity?A) Treadmill walking at 60% of maximal heart rate, continuous for 30 minutesB) Walking to the point of moderate pain, resting, and repeating for 30 minutes totalC) Interval walking at high intensity with short rest breaksD) Walking with partial body weight support to reduce claudication painDOWNLOAD THIS EPISODES CHEATSHEET:www.nptecheatsheet.com/PAD1

During this heartfelt interview, Marcia opens up about her personal battle with Peripheral Artery Disease (PAD) — a condition that affects one in five people over age 60 and kills more people than cancer. Marcia discusses how, after suffering pain for two years and undergoing procedures to save her right big toe, she ultimately had to face the difficult experience of a toe amputation. Despite these challenges, she has become a fierce advocate for PAD awareness.Recognizing the Signs of Peripheral Artery Disease:Marcia shares the critical symptoms of PAD, which include:Cold feetPain or tightness in the calves when walkingMuscle spasmsDiscoloration in the toes or legsLoss of hair growth on the legsBecome a supporter of this podcast: https://www.spreaker.com/podcast/chatting-with-betsy--4211847/support.

Jamil Matthews, MD, vascular and endovascular surgeon, discusses Peripheral Artery Disease and Venous Disease, signs symptoms, prevention and treatment options.

Join us as Dr. Syed Hussain unpacks the essentials of Peripheral Artery Disease, commonly known as PAD. This episode covers what PAD is, its symptoms, risk factors, and why it's often overlooked compared to other cardiovascular diseases. Discover how you can recognize the signs and take proactive steps toward your vascular health.

In this episode, Dr. Valentin Fuster discusses a groundbreaking study that explores the role of remnant cholesterol in peripheral arterial disease, revealing it as a stronger and more direct cause of the disease than LDL cholesterol. The findings challenge traditional views on lipid management, emphasizing the need for targeted therapies to address remnant cholesterol and reduce cardiovascular risks.

BUFFALO, NY — March 12, 2025 — A new #research paper was #published in Aging (Aging-US) on February 25, 2025, Volume 17, Issue 2, titled “Epidemiology and genetic determination of measures of peripheral vascular health in the Long Life Family Study.” Researchers from multiple institutions, led by first author and corresponding author Deidra R. Fricke from the University of Pittsburgh, studied the genetic and lifestyle factors that influence peripheral artery disease (PAD), a condition that restricts blood flow to the legs. Their findings suggest that people from families with exceptional longevity have a lower risk of PAD, possibly due to inherited genetic traits or healthier lifestyle habits. Peripheral artery disease is a common but often undiagnosed condition that affects millions worldwide. It increases the risk of heart disease, stroke, and mobility issues. This study conducted using data from the Long Life Family Study (LLFS), found that individuals from long-lived families have significantly better vascular health than the general population. “Peripheral artery disease (PAD) is a major contributor to morbidity in older adults.” The researchers analyzed over 3,000 participants, including 1,090 long-lived individuals, their 1,554 children, and 362 spouses. Among the oldest participants (average age 89), about 18% had PAD. However, among their children (average age 60), only 1% had PAD—far lower than the expected 12% found in other studies. This finding suggests that certain protective factors, whether genetic or lifestyle-related, help maintain healthier arteries in these families. In the study, key risk factors for PAD were identified, including aging, high blood pressure, smoking, and hypertension medication use. Interestingly, unlike in other studies, high cholesterol and diabetes were not major risk factors in this group. This data further supports the idea that long-lived families may have genetic protective factors that contribute to better vascular health. In addition to lifestyle factors, the study found four genomic regions linked to PAD risk. Three of these were new discoveries, while the fourth was similar but not identical to previously published findings. These genetic markers may help scientists better understand why some individuals are more likely to develop PAD and how to prevent it. “We identified four genomic sites that may harbor variants associated with protection from PAD.” This research highlights the value of studying long-lived families to unlock the secrets of healthy aging and vascular health. Understanding what helps them maintain better artery function could lead to new strategies for preventing PAD, heart disease, and other age-related conditions. Paper DOI: https://doi.org/10.18632/aging.206204 Corresponding author: Deidra R. Fricke — der94@pitt.edu Keywords: aging, ankle-brachial index, peripheral arterial disease, heritability, genomewide linkage analysis, genomewide association study Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts About Aging-US The mission of the journal is to understand the mechanisms surrounding aging and age-related diseases, including cancer as the main cause of death in the modern aged population. The journal aims to promote 1) treatment of age-related diseases by slowing down aging, 2) validation of anti-aging drugs by treating age-related diseases, and 3) prevention of cancer by inhibiting aging. (Cancer and COVID-19 are age-related diseases.) Please visit our website at https://www.Aging-US.com​​ and connect with us: Facebook - https://www.facebook.com/AgingUS/ X - https://twitter.com/AgingJrnl Instagram - https://www.instagram.com/agingjrnl/ YouTube - https://www.youtube.com/@AgingJournal LinkedIn - https://www.linkedin.com/company/aging/ Pinterest - https://www.pinterest.com/AgingUS/ Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc MEDIA@IMPACTJOURNALS.COM

Join Emmy Award-winning journalist Kym McNicholas and Interventional Cardiologist Dr. John Phillips in this eye-opening episode of "The Heart of Innovation." Discover the alarming gaps in healthcare that contribute to inadequate care for patients with Peripheral Artery Disease (PAD), a condition deadlier than breast, colon, and prostate cancers combined. Learn how the Global PAD Association is bridging these gaps, saving lives, and preventing amputations. If you experience leg pain, cramps, neuropathy, or sleepy legs, contact the Leg Saver Hotline at (415) 320-7138 or visit PADhelp.org for assistance. Don't miss this crucial conversation on improving PAD care and advocacy!

Dr. Amy Reed discusses what Peripheral Artery Disease is, its symptoms and typical treatments. She also shares how you can help prevent the disease.

The Heart of Innovation host Kym McNicholas talks to El Paso Cardiology Associates Interventional Cardiologist Dr. Laiq Raja about the formation of the "Limb Savers Society" in El Paso, Texas and how El Paso Cardiovascular Associates' Peripheral Artery Disease treatment program has earned the designation as a Center of Excellence, one of only two in the Country. The mission of the Limb Savers Society is to provide education, advocacy and support research to help prevent unnecessary amputations in the El Paso community by promoting multidisciplinary team-based treatment for patients with peripheral artery disease, critical limb ischemia and non-healing wounds.   Their annual one-day physician and clinician education event, CLIF Conference is taking place on Saturday, December 14, 2024 and show host Kym McNicholas is one of the speakers at the event as well as the Global PAD Association Board Member Dr. David Alper and strategic advisor Dr. Craig Walker. We talk about the event and the importance of educating other clinicians and physicians about advances in limb salvage to continue to reduce amputations for Peripheral Artery Disease and its advanced stage, known as Critical Limb Ischemia. For more information on the event, go to CLIFconference.org.

Optimal Medical Therapy in Peripheral Artery Disease   Guest: Stan Henkin, M.D. Host: Malcolm R. Bell, M.D.   Atherosclerosis of peripheral (ie, non-coronary) arteries, also known as peripheral artery disease (PAD), affects more than 8 million Americans. Unfortunately, compared to coronary artery disease (CAD), PAD is often underdiagnosed and undertreated. In this podcast, experts discuss optimal medical therapy in patients with PAD.   Topics Discussed: What is peripheral artery disease? What are the most common symptoms of PAD? You diagnose PAD. What pharmacologic and non-pharmacologic therapies do you consider? How do you follow-up a patient with PAD? When should a patient be referred to a vascular specialist?   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here.

A 67 year old woman with a history of hypertension, hyperlipidemia, diabetes, and a 25 pack year smoking history is referred your clinic and is referred for evaluation of her peripheral arterial disease. She reports pain with walking that has limited her doing some daily activities. How can you optimally manage this patient? Does she need an operation? In this episode, we will cover the basics of peripheral arterial disease, discuss the specifics of optimal medical management and dive into the nuances of when (or if) you should offer these patients an operation.  Hosts:  Dr. Bobby Beaulieu is an Assistant Professor of Vascular Surgery at the University of Michigan and the Program Director of the Integrated Vascular Surgery Residency Program as well as the Vascular Surgery Fellowship Program at the University of Michigan. Dr. Drew Braet is a PGY-5 Integrated Vascular Surgery Resident at the University of Michigan Learning Objectives - Review the definition, prevalence, and risk factors for peripheral arterial disease - Understand the specifics of optimal medical management of patients with peripheral arterial disease  - Discuss the controversy regarding operative management of patients with claudication and review indications for an operation in patients with peripheral arterial disease - Review the appropriate anti-platelet and anti-coagulation strategies after interventions in patients with peripheral arterial disease References 1.    Woo K, Siracuse JJ, Klingbeil K, Kraiss LW, Osborne NH, Singh N, Tan TW, Arya S, Banerjee S, Bonaca MP, Brothers T, Conte MS, Dawson DL, Erben Y, Lerner BM, Lin JC, Mills JL Sr, Mittleider D, Nair DG, O'Banion LA, Patterson RB, Scheidt MJ, Simons JP; Society for Vascular Surgery Appropriateness Committee. Society for Vascular Surgery appropriate use criteria for management of intermittent claudication. J Vasc Surg. 2022 Jul;76(1):3-22.e1. doi: 10.1016/j.jvs.2022.04.012. Epub 2022 Apr 22. PMID: 35470016. https://pubmed.ncbi.nlm.nih.gov/35470016/ 2.    Nordanstig J, Behrendt CA, Baumgartner I, Belch J, Bäck M, Fitridge R, Hinchliffe R, Lejay A, Mills JL, Rother U, Sigvant B, Spanos K, Szeberin Z, van de Water W; ESVS Guidelines Committee; Antoniou GA, Björck M, Gonçalves FB, Coscas R, Dias NV, Van Herzeele I, Lepidi S, Mees BME, Resch TA, Ricco JB, Trimarchi S, Twine CP, Tulamo R, Wanhainen A; Document Reviewers; Boyle JR, Brodmann M, Dardik A, Dick F, Goëffic Y, Holden A, Kakkos SK, Kolh P, McDermott MM. Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication. Eur J Vasc Endovasc Surg. 2024 Jan;67(1):9-96. doi: 10.1016/j.ejvs.2023.08.067. Epub 2023 Nov 10. PMID: 37949800. https://pubmed.ncbi.nlm.nih.gov/37949800/ 3.    Gornik HL, Aronow HD, Goodney PP, Arya S, Brewster LP, Byrd L, Chandra V, Drachman DE, Eaves JM, Ehrman JK, Evans JN, Getchius TSD, Gutiérrez JA, Hawkins BM, Hess CN, Ho KJ, Jones WS, Kim ESH, Kinlay S, Kirksey L, Kohlman-Trigoboff D, Long CA, Pollak AW, Sabri SS, Sadwin LB, Secemsky EA, Serhal M, Shishehbor MH, Treat-Jacobson D, Wilkins LR. 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024 Jun 11;149(24):e1313-e1410. doi: 10.1161/CIR.0000000000001251. Epub 2024 May 14. PMID: 38743805. https://pubmed.ncbi.nlm.nih.gov/38743805/ 4.    Belch JJ, Dormandy J; CASPAR Writing Committee; Biasi GM, Cairols M, Diehm C, Eikelboom B, Golledge J, Jawien A, Lepäntalo M, Norgren L, Hiatt WR, Becquemin JP, Bergqvist D, Clement D, Baumgartner I, Minar E, Stonebridge P, Vermassen F, Matyas L, Leizorovicz A. Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg. 2010 Oct;52(4):825-33, 833.e1-2. doi: 10.1016/j.jvs.2010.04.027. Epub 2010 Aug 1. Erratum in: J Vasc Surg. 2011 Feb;53(2):564. Biasi, B M [corrected to Biasi, G M]. PMID: 20678878. https://pubmed.ncbi.nlm.nih.gov/20678878/ 5.    Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, Diaz R, Alings M, Lonn EM, Anand SS, Widimsky P, Hori M, Avezum A, Piegas LS, Branch KRH, Probstfield J, Bhatt DL, Zhu J, Liang Y, Maggioni AP, Lopez-Jaramillo P, O'Donnell M, Kakkar AK, Fox KAA, Parkhomenko AN, Ertl G, Störk S, Keltai M, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Verhamme PB, Vinereanu D, Kim JH, Tonkin AM, Lewis BS, Felix C, Yusoff K, Steg PG, Metsarinne KP, Cook Bruns N, Misselwitz F, Chen E, Leong D, Yusuf S; COMPASS Investigators. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. N Engl J Med. 2017 Oct 5;377(14):1319-1330. doi: 10.1056/NEJMoa1709118. Epub 2017 Aug 27. PMID: 28844192. https://pubmed.ncbi.nlm.nih.gov/28844192/ 6.    Bonaca MP, Bauersachs RM, Anand SS, Debus ES, Nehler MR, Patel MR, Fanelli F, Capell WH, Diao L, Jaeger N, Hess CN, Pap AF, Kittelson JM, Gudz I, Mátyás L, Krievins DK, Diaz R, Brodmann M, Muehlhofer E, Haskell LP, Berkowitz SD, Hiatt WR. Rivaroxaban in Peripheral Artery Disease after Revascularization. N Engl J Med. 2020 May 21;382(21):1994-2004. doi: 10.1056/NEJMoa2000052. Epub 2020 Mar 28. PMID: 32222135. https://pubmed.ncbi.nlm.nih.gov/32222135/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

This week, I talked a bit about how I manage intermittent fatigue, mostly with taking breaks and getting enough sleep! Like a lot of us, I’m guilty of pushing myself to get stuff done until I drop, and I need to learn to rest more.  Then we discussed the possibility that Ron has intermittent claudication, a […]

Dr. Ethan Korngold is the chief medical officer and divisional vice president of medical affairs at Abbott's vascular business, which has developed a dissolvable stent technology to treat peripheral artery disease. PAD disproportionately affects Black and Hispanic communities and is often overlooked because early symptoms can be mistaken for other conditions. The Esprit BTK stent can help open up the smaller arteries below the knee and improve blood flow to the legs and feet to treat PAD and prevent severe complications and amputations. Ethan explains, "So peripheral artery disease refers to blockages in the arteries to the legs. When those blockages build up, it's because of cholesterol typically that builds up in the walls of the artery and causes limited blood flow. Initially, people can have cramping or soreness in their legs when they walk. That gets better with rest. As the blockages get worse, people can develop infections, ulcers, or non-healing wounds of their legs with what we call chronic limb-threatening ischemia. And ultimately, that can put people at risk for amputation." "A lot of people aren't aware of how common it is, and a lot of people aren't attuned to the symptoms of it. People just sort of slow down. They do less and less, and they wind up being limited in their activities, and that really affects their health and their life, and ultimately, that can threaten their limbs. One of the things that Abbott is emphatic about is spreading awareness of the disease, trying to educate patients, trying to educate families, and trying to educate physicians so that people are more on guard for looking out for the signs and symptoms of the disease." "We have been working at Abbott for many years on techniques to help open up these blockages in the arteries of the legs. They start at about the belly button and go all the way down to the toes. At the belly button, the iliac arteries are quite large. They are about a half an inch in diameter. And then, as they go down all the way to the toes, they get narrower and narrower so that they're about a quarter of an inch to an eighth of an inch in diameter. There are a variety of different techniques to get through those blockages, such as using catheters, and wires balloons, and stents and scaffolds to help open up those arteries and change people's lives. One of the biggest challenges in this space has been those smaller arteries below the knee." #Abbott #AbbottVascular #PeripheralArteryDisease #PAD #DissolvableStentTechnology abbott.com PAD-info.com Download the transcript here

Dr. Ethan Korngold is the chief medical officer and divisional vice president of medical affairs at Abbott's vascular business, which has developed a dissolvable stent technology to treat peripheral artery disease. PAD disproportionately affects Black and Hispanic communities and is often overlooked because early symptoms can be mistaken for other conditions. The Esprit BTK stent can help open up the smaller arteries below the knee and improve blood flow to the legs and feet to treat PAD and prevent severe complications and amputations. Ethan explains, "So peripheral artery disease refers to blockages in the arteries to the legs. When those blockages build up, it's because of cholesterol typically that builds up in the walls of the artery and causes limited blood flow. Initially, people can have cramping or soreness in their legs when they walk. That gets better with rest. As the blockages get worse, people can develop infections, ulcers, or non-healing wounds of their legs with what we call chronic limb-threatening ischemia. And ultimately, that can put people at risk for amputation." "A lot of people aren't aware of how common it is, and a lot of people aren't attuned to the symptoms of it. People just sort of slow down. They do less and less, and they wind up being limited in their activities, and that really affects their health and their life, and ultimately, that can threaten their limbs. One of the things that Abbott is emphatic about is spreading awareness of the disease, trying to educate patients, trying to educate families, and trying to educate physicians so that people are more on guard for looking out for the signs and symptoms of the disease." "We have been working at Abbott for many years on techniques to help open up these blockages in the arteries of the legs. They start at about the belly button and go all the way down to the toes. At the belly button, the iliac arteries are quite large. They are about a half an inch in diameter. And then, as they go down all the way to the toes, they get narrower and narrower so that they're about a quarter of an inch to an eighth of an inch in diameter. There are a variety of different techniques to get through those blockages, such as using catheters, and wires balloons, and stents and scaffolds to help open up those arteries and change people's lives. One of the biggest challenges in this space has been those smaller arteries below the knee." #Abbott #AbbottVascular #PeripheralArteryDisease #PAD #DissolvableStentTechnology abbott.com PAD-info.com Listen to the podcast here

Historically, the high-tech industry has not been known for gender diversity and creating opportunities for women... Will history repeat itself with the Artificial Intelligence boom, or does AI provide a chance to reset the paradigm? (at 15:30) --- To Your Health: How much do you know about the symptoms and effects of Peripheral Artery Disease? Even though it affects a significant number of older adults, most aren't aware of their risk (at 24:02) --- What's Happening: We get an update on October programs and fun at the Findlay YMCA (at 43:25)

On this episode of The Heart of Innovation with Emmy Award-winning journalist and Interventional Cardiologist Dr. John Phillips, meet the "Vascular Luminary of the Year" award winner as recognized by the Global PAD Association. This award recognizes a doctor who excels in research, policy change, and advocacy around preventing, treating, and managing PAD and through these efforts, is helping to create the change patients want to see in care. This individual influences clinical practices, and dedicates efforts towards educating both the medical community and the public.  Dr. Athanasios Saratzis, from Leicester, England is the Global PAD Association's "Vascular Luminary of the Year" award winner due to his relentless commitment to improving patient outcomes, advancing the field of PAD research, and fostering a healthier, more informed society. Watch this episode to hear more about Dr. Saratzis powerful plight to save life and limb across the globe.

In the September 3rd, 2024 issue of JACC, a new scientific statement delves into antithrombotic strategies for peripheral artery disease (PAD), highlighting the challenges and advancements in treatment. The review emphasizes that while traditional therapies like aspirin and clopidogrel remain crucial, combining aspirin with low-dose rivaroxaban offers a promising approach for reducing major adverse events and limb outcomes, despite an increased bleeding risk.

Can a twice-yearly shot provide 100% protection against HIV? Find out about this and more in today's PeerDirect Medical News Podcast.

If your doctor can't figure out why you have pain, cramping, burning, tingling, cold foot, or numbness in the back of your calf, it might be Popliteal Artery Entrapment Syndrome (PAES). Symptoms can often mimic that of Peripheral Artery Disease (PAD). Those symptoms, coupled with additional swelling, heavy legs, and even a blood clot may also indicate Vein Entrapment. Vascular Surgeon DR. Krishna Mannava, with Vive Vascular in Ohio has seen an increase in the number of patients and talks to hosts Kym McNicholas and Interventional Cardiologist Dr. John Philips about Why PAES is often overlooked and innovative approaches to ensure patients don't progress to amputation with this disorder.

Jennifer Jones-McMeans, divisional vice president of global clinical affairs at Abbott's vascular business, and Dr. Brian DeRubertis, a doctor at the New York-Presbyterian Weill Cornell Medical Center, shine a light on peripheral artery disease and critical limb-threatening ischemia where artery blockage restricts blood flow to the lower legs. Abbott has developed the Esprit, a dissolving scaffold that opens up the artery in the blocked area and elutes a drug that slows disease progression. Their LIFE-BTK trial demonstrated success in a diverse patient population and is a significant new treatment option for CLTI.  Brian explains, "One of the things that I'll say is our group is starting to explore doing additional efforts at patient education with our own patients, patients who have actually been diagnosed with this disease, and educating them a little bit more about what it means to have this disease, how they can be involved in the process of trying to prevent their disease from getting worse. And the reason we're doing this is exactly what you said. Everyone knows what a heart attack is, but very few people understand that the same process that leads to clogged arteries in the heart or blocked arteries in the heart can lead to blocked arteries in the legs. Those blockages can ultimately lead to amputation. And so, the education of patients and keeping them informed about the disease process is one important part of this."  Jennifer elaborates, "This is really a landmark moment for people with this severe form of peripheral artery disease, which we're calling CLTI. When you think of these minimally invasive procedures to treat this disease, currently in the United States, you only have plain balloon angioplasty. And this is what the LIFE BTK trial was measured against. The Esprit was measured, which is our dissolving stent, and tested against the standard of care, plain balloon angioplasty. And it's been decades since there's been any innovation in this, what they sometimes call the endovascular first space. The Esprit is made out of a polymer material similar to what you would think about with dissolving stitches, and it also has a drug on it." #Abbott #CLTI #PeripheralArteryDisease #PAD #LegArteries #PlainBalloonAngioplasty #DiversityinClinicalTrials abbott.com Download the transcript here

Jennifer Jones-McMeans, divisional vice president of global clinical affairs at Abbott's vascular business, and Dr. Brian DeRubertis, a doctor at the New York-Presbyterian Weill Cornell Medical Center, shine a light on peripheral artery disease and critical limb-threatening ischemia where artery blockage restricts blood flow to the lower legs. Abbott has developed the Esprit, a dissolving scaffold that opens up the artery in the blocked area and elutes a drug that slows disease progression. Their LIFE-BTK trial demonstrated success in a diverse patient population and is a significant new treatment option for CLTI.  Brian explains, "One of the things that I'll say is our group is starting to explore doing additional efforts at patient education with our own patients, patients who have actually been diagnosed with this disease, and educating them a little bit more about what it means to have this disease, how they can be involved in the process of trying to prevent their disease from getting worse. And the reason we're doing this is exactly what you said. Everyone knows what a heart attack is, but very few people understand that the same process that leads to clogged arteries in the heart or blocked arteries in the heart can lead to blocked arteries in the legs. Those blockages can ultimately lead to amputation. And so, the education of patients and keeping them informed about the disease process is one important part of this."  Jennifer elaborates, "This is really a landmark moment for people with this severe form of peripheral artery disease, which we're calling CLTI. When you think of these minimally invasive procedures to treat this disease, currently in the United States, you only have plain balloon angioplasty. And this is what the LIFE BTK trial was measured against. The Esprit was measured, which is our dissolving stent, and tested against the standard of care, plain balloon angioplasty. And it's been decades since there's been any innovation in this, what they sometimes call the endovascular first space. The Esprit is made out of a polymer material similar to what you would think about with dissolving stitches, and it also has a drug on it." #Abbott #CLTI #PeripheralArteryDisease #PAD #LegArteries #PlainBalloonAngioplasty #DiversityinClinicalTrials abbott.com Listen to the podcast here

Commentary by Dr. Valentin Fuster

Join us on the podcast as we delve into the hidden epidemic affecting Black and brown communities: peripheral artery disease (PAD). Our guest, Anahita Dua, a vascular surgeon, sheds light on the alarming prevalence of PAD and its devastating consequences. From discussing the primary risk factors to exploring the importance of early detection and treatment, we uncover the critical steps needed to address this public health crisis. Anahita Dua is a vascular surgeon. She discusses the KevinMD article, "Preventing amputations and saving lives starts with bringing PAD into the 21st century." Mentioned in the episode: Get a Pulse on PAD (https://padpulse.org/) Our presenting sponsor is Nuance, a Microsoft company. Do you spend more time on administrative tasks like clinical documentation than you do with patients? You're not alone. Clinicians report spending up to two hours on administrative tasks for each hour of care provided. Nuance, a Microsoft company, is committed to helping clinicians restore the balance with Dragon Ambient eXperience – or DAX for short. DAX is an AI-powered, voice-enabled solution that helps physicians cut documentation time in half. DAX Copilot combines proven conversational and ambient AI with the most advanced generative AI in a mobile application that integrates directly with your existing workflows. DAX Copilot can be easily enabled within the workflow of the Dragon Medical application to bring the power of ambient technology to more clinicians faster while leveraging the proven and powerful capabilities used by over 550,000 physicians. Explore DAX Copilot today. Visit https://nuance.com/daxinaction to see a 12-minute DAX Copilot demo. Discover clinical documentation that writes itself and reclaim your work-life balance. VISIT SPONSOR → https://nuance.com/daxinaction SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended GET CME FOR THIS EPISODE → https://earnc.me/9zyfw6 Powered by CMEfy.

Commentary by Dr. Valentin Fuster

A new study in Science Direct, shows a disturbing trend in a younger demographic of patients with an advanced stage of Peripheral Artery Disease, or poor circulation in their legs. It's known as Critical Limb Ischemia (CLI). The study shows an increase in CLI patients age 18 to 40 from 2016 – 2020. One reason is an increase in adolescent diabetes T2. Another reason is doctors telling patients they're too young to have poor circulation. It's typically an ‘old person's disease'. So, younger patients who experience leg pain and leg cramps are brushed off in early stages, leaving their disease to advance to a point where they're a toe stub away from amputation with their arteries blocked extensively, restricting blood flow to their feet. The key is to educate primary care doctors and podiatrists about PAD and arm them with the ability to test for it so that patients can get diagnosed sooner when conservative treatment, which consists of medication, insulin control, and lifestyle modifications, is enough to stall disease progression. That's why the Global PAD Association is partnering with PAD test maker Biomedix, to help patients find a primary care doctor or podiatrist who have additional experience with PAD and offer a test in their clinic. Biomedix CEO John Romans talks about the partnership which includes the launch of PADtest.org where patients can search for a doctor with their PADnet test in office in case it's medically appropriate to conduct additional vascular assessment upon presentation of PAD symptoms, which may include neuropathy, leg cramps, leg pain, heaviness, or weakness. 

On this episode of Let's Talk Business Podcast, Dr. Martinez unveils his revolutionary techniques in limb salvage! Show Guest: Dr. Jeffrey Martinez Espada Vascular (Limb Salvage and Amputation Prevention) 830-632-7931 Join the "Let's Talk Business" podcast community on Patreon to engage with show hosts, guests, and fans. You'll also get exclusive content, member shoutouts on the show and early access to in-person events.   Get access here: patreon.com/letstalkbusiness #SanAntonioBusinessPodcast #SanAntonioBusiness #SanAntonio ▶ Subscribe to our YouTube Channel: https://goo.gl/dzqVGV Host: ✅ Marc Ebinger

What is Peripheral Artery Disease (PAD) and How common is it?Is vascular disease sometimes a sign of another underlying health issue?

Commentary by Dr. Valentin Fuster

Diabetes has a deadly secret. Even one extra sugar molecule floating around your blood can damage your arteries putting you at risk for heart attack, stroke, and amputation. ABC News Live Correspondent Steve Osunsami knows this all too well from watching his Dad suffer from Diabetes and one of its most prevalent and deadly complications, known as Peripheral Artery Disease, which is poor circulation mainly in the legs due to plaque build-up. In this episode, Steve talks to The Heart of Innovation's Kym McNicholas and Dr. John Phillips about his Dad's story and its influence on pitching his team to do a story to spread awareness of the diabetes epidemic and the serious repercussions of not getting it under control, and fast. Tune into this episode to hear the backstory of the new ABC News Live feature, "Severed," in which a dozen ABC team members who worked on it all were personally impacted by diabetes and/or related amputations. 

Have you ever heard of PAD? Chances are you haven't even though it is the leading cause of amputations in the U.S. A new campaign hopes to raise awareness.

This week on *The Heart of Innovation*, hosted by Interventional Cardiologist Dr. John Phillips and Emmy Award-winning journalist Kym McNicholas, the focus is on the relationship between leg pain and heart health. Since February is American Heart Month, we invited Interventional Cardiologist Dr. Jason Yoho, who practices in San Antonio and Corpus Christi, Texas, and his patient Douglas, to share a life-saving story. Douglas had what's called, Peripheral Artery Disease, which is poor circulation in mainly the leg arteries, and doctors didn't check his heart arteries until it was almost too late. Did you know that three-in-five people who suffer a heart attack have plaque in their leg arteries? If only a doctor would have checked their leg pulses regularly, life and limb might be saved. In this episode, we hope you learn from Douglas' story, including the critical tests and questions to discuss with your doctor.

More than 3 million Americans are diagnosed with peripheral artery disease, or PAD, each year. Dr. Nirav Shah discusses diagnosis, prevention, and possible treatment options.

In this episode of The Backtable Podcast, host Dr. Aaron Fritts and guests Dr. Mahmood Razavi and Dr. Mark Garcia discuss the intricacies of owning and operating an outpatient-based lab (OBL). Dr. Razavi and Dr. Garcia are practicing interventional radiologists at Vascular and Interventional Specialists of Orange County (California) and American Vascular Associates (Florida), respectively. The doctors explore the advantages of OBLs, including autonomy, flexibility, and patient satisfaction. They also delve into the challenges of financial sustainability, decision-making restrictions, and insurance navigation. The conversation revolves around the need for a solid business plan before stepping into OBL operation. This includes awareness of potential regulatory oversight, costs, and patient sources. They also discuss the impact of OBLs on healthcare, and they specifically warn that the lack of evidence-based practices might have adverse effects. The doctors propose solutions such as societal guidelines, required accreditation, and stringent care delivery. --- CHECK OUT OUR SPONSOR Siemens Healthineers https://www.siemens-healthineers.com/ --- SHOW NOTES 00:00 - Introduction 04:26 - Pros and Cons of Owning and Operating in an OBL 11:07 - Financial Aspects and Profitability of OBLs 23:42 - Exploring Alternative Models for OBLs 32:33 - The Role of Societies in Guiding OBL Practices 36:27 - The Future of OBLs: Regulation, Consolidation, and Quality 42:59 - Exit Strategies and Future Considerations for OBLs 50:38 - Final Thoughts on OBLs and the Importance of Quality Care --- RESOURCES Impact of Office Based Laboratories on Physician Practice Patterns and Outcomes after Percutaneous Vascular Interventions for Peripheral Artery Disease: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555658/pdf/nihms-1524412.pdf

Doctors don't always have the opportunity to hear about the impact they've had on their patients. So, Interventional Cardiologist Dr. John Phillips and Emmy Award-winning journalist/patient advocate Kym McNicholas talk to patients who have a disease that's deadlier than all cancers combined, except lung cancer, called Peripheral Artery Disease (PAD). PAD is a circulation issue in the legs that left untreated can lead to amputation, stroke, and heart attack. Patient Alan offers his thanks to Dr. Kumar Madassery at Rush Hospital as well as Dr. Jihad Mustapha at Advanced Cardiac and Vascular Centers in Michigan, along with his vascular surgeons in Indiana. Nancy thanks Dr. James Antezana, a vascular surgeon in Charlotte, North Carolina for his care. Charles shares his appreciation for Dr. Michael Siah, a vascular surgeon in Dallas for saving his limbs as well as TheWayToMyHeart.org for supporting his wife through the journey. And Douglas shares his appreciation for Dr. Mehrzad Zarghouni for not only saving his legs but also his life. 

Commentary by Dr. Valentin Fuster

Commentary by Dr. Valentin Fuster

Join InpharmD as we discuss the role of apixaban in peripheral artery disease.

We were live ahead of the The African American Male Wellness Agency Walk in Los Angeles talking to their director Jhade Barnes to talk about the need to improve access and care for African American Men. Since 2004, The AAMW agency has produced a 5K Walk & Run (The Walk) in over 15 cities as an awareness campaign to spotlight the fact that Black Men get Peripheral Artery Disease and Diabetes related amputations at 4x that of their white counterparts and die on average 12 years earlier than their white counterparts. They have incredible partners such as Johnson & Johnson and The Janssen Pharmaceutical Companies of Johnson & Johnson that provide free testing and information to help Black men live longer from preventable diseases like PAD. This year The Way To My Heart, EZ Care Link, and Philips Healthcare had the opportunity to provide support for this wonderful mission! Celebrity fitness trainer Dion Jackson was also at the event to help inspire better health through exercise. 

Individuals with Peripheral Artery Disease (PAD) describe the pain caused by artery blockages restricting blood flow to their feet as having a tourniquet wrapped tightly around their thigh and calf causing their muscles, tissues, and nerves below to scream for much needed oxygen and other nutrients. Timing is critical to diagnose and treat PAD whether with medication, lifestyle modifications, and/or interventional/surgical approaches because once tissue and nerves are damaged due to lack of blood flow,pain may be permanent. Few options are available to bring relief for that neuropathy pain and chiropractic and general wellness practices across the country are preying upon these individuals with band-aid options which come at a high price. But some physicians are working on clinical solutions that are much more effective and durable for these patients who have had their blood flow restored and still can't get relief from PAD, diabetic neuropathy, or even phantom pain following amputation. Southern Vascular & Pain Management Center Interventional Radiologists Dr. Stephen Leschak and Dr. Thomas Hodgkiss join Emory University Vice Chair for imaging intervention and division director for interventional radiology Dr. David Prologo in talking about innovative approaches to managing pain and questions to ask your doctor to know if they're right for you.

Live Nursing Review with Regina MSN, RN! Every Monday & Wednesday we are live. LIKE, FOLLOW, & SUB @ReMarNurse for more.     Sign up for the NCLEX 30-Day Challenge Review now at http://www.ReMarNurse.com/30Days   Quick Facts for NCLEX Next Gen Study Guide here - https://bit.ly/QF-NGN Study with Professor Regina MSN, RN every Monday as you prepare for NCLEX Next Gen.   ► Create Free V2 Account - http://www.ReMarNurse.com ► Get Quick Facts Next Gen - https://bit.ly/QF-NGN ► Subscribe Now - http://bit.ly/ReMar-Subscription ► GET THE PODCAST: https://remarnurse.podbean.com/ ► WATCH LESSONS: http://bit.ly/ReMarNCLEXLectures/ ► FOLLOW ReMar on Instagram: https://www.instagram.com/ReMarNurse/ ► LIKE ReMar on Facebook: https://www.facebook.com/ReMarReview/   ReMar Review features weekly NCLEX review questions and lectures from Regina M. Callion MSN, RN. ReMar is the #1 content-based NCLEX review and has helped thousands of repeat testers pass NCLEX with a 99.2% student success rate! ReMar focuses on 100% core nursing content and as a result, has the best review to help nursing students to pass boards - fast!

Joining us on Well Said is Dr. Mitchell Weinberg, Chair of Cardiology at Staten Island University Hospital and an Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell to discuss Peripheral Artery Disease – a common, although often serious condition in which narrowed arteries reduce blood flow to the arms or legs.

In this episode, Dr. Andrea Um leads a discussion focusing on peripheral

Deion Sanders courageously shared his struggles with a circulation issue that puts him at-risk of losing his foot in a video posted on social media. It may have been left on the editing room floor, but critical information about this circulation issue and treatment options to prevent amputation were not shared in the video or across other media covering this story. In this episode, hosts Emmy Award-winning Journalist Kym McNicholas and Interventional Cardiologist Dr. John Phillips are joined by specialists trained in advanced treatment of this circulation known as peripheral artery disease (PAD) and its advanced stage critical limb ischemia CLI), a circulation issue characterized by narrowed or blocked arteries due to plaque such as blood clots and/or calcium, which can cause leg pain, leg cramps, non-healing wounds, and more.Interventional Cardiologist Dr. Jihad Mustapha, and Vascular Surgeons Dr. James Antezana and Dr. William Shutze talk about what you need to know about this circulation issue, which is one of the most debilitating diseases most have never heard of, yet impacts 3-in-5 heart attack sufferers, 1-in-5 over age 60, and 1-in-3diabetics (Type 1 and Type 2 diabetics) over the age of 50. Importantly, they'll share advances in treatment and amputation prevention as well as the standards of care patients should expect from their physicians treating it.

Many individuals who suffer from vascular diseases such as Peripheral Artery Disease and Chronic Venous Insufficiency are plagued with chronic pain. This ongoing pain can cause a sense of helplessness and frustration, as those affected struggle to regain control over their lives. Take Helen, for example, who finds herself buried under medical bills and unsure of where to turn for relief. She doesn't want to burden her family, but the prospect of managing her chronic pain seems overwhelming. In this episode, Helen shares her story about how she ended up determining that jail was her only option for medical care and pain relief.Kathryn Walker, Psychiatric Nurse Practitioner and CEO of Rivitalist, a wellness healthcare chain, helps Helen walk us through her story and what was going through her mind when she was arrested as she pretended to attempt to steal items from a Georgia Walmart. Christopher Stout, a vascular surgeon,contributes to the conversation by highlighting the challenges faced by patients with PAD and CVI, such as delayed care, insurance obstacles, and gaps between diagnosis and treatment. These issues can result in chronic pain that can significantly impact patients' daily lives and mental well-being.

Marathon runner Mark Easter is traveling the world to raise awareness for Peripheral Artery Disease (P.A.D.), a circulation issue impacting mainly the leg arteries. He shares why this cause is personal to him and what is powering every step he takes to the finish line. He'll also talk about the races he will run this year, how you can follow his successes, and support his campaign to reduce P.A.D. related amputations. In this episode of Save My Piggies, Jesse Waters shares his P.A.D. journey and how an early diagnosis led to lifestyle modifications which have stalled progression of this disease.

A study released in 2019 in the Journal of the American Society of Nephrology states that 1 in 10 people with end-stage renal disease, which is those who have kidney disease and are on dialysis, undergo a major amputation of one of their legs in their last year of life. How does kidney disease lead to leg loss. That's the heart of this episode's discussion. If you've listened to this show for awhile, co-hosts Kym McNicholas and Dr. John Phillips talk a lot about Peripheral Artery Disease, which is plaque build-up in mainly the leg arteries, that restricts blood flow to the feet, leading to amputation. A new study by Interventional cardiologists at the University of Pennsylvania, that was presented at the Society of Interventional Radiology (SIR) Annual Scientific Meeting recently, reinforces conclusions of previous studies that people with end stage kidney disease are more likely to undergo lower extremity amputation. We have Dr. Rotimi Badero an Interventional CardioNephrologist - a very unique practice, who will talk about this serious issue, which impacts 10% of medicare fee for service spending.